Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Too-Rapid Adoption Of Telehealth Can Lead To Suboptimal Patient Care, ECRI Says

FDA has also revoked some EUAs after a closer look at authorized device, group warns

Executive Summary

Telehealth programs may cause risks to patients if they don’t provide sufficient user training or prove unable to overcome technology inequalities, ECRI says.

You may also be interested in...



Safety Group ECRI Reminds Hospitals That FDA’s EUA Process A ‘Lower Standard’ For Device Approvals

The nonprofit patient safety group ECRI that focuses on device safety and efficacy warns about medtech with EUAs in its “2021 Top 10 Health Technology Hazards.”

FDA Sets New Restrictions For Authorized N95 Decontamination Systems

After reviewing real-world data, the US agency says the decontamination systems should only be used for compatible facemasks and should not be used to clean a mask more than four times.

White House To Deliver 25 Million Face Masks To Low-Income Americans

The White House will be spending $86m to provide tens of millions of coronavirus masks to poorer American households.

Topics

UsernamePublicRestriction

Register

MT143514

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel